Close
ACHEMA MIDDLE EAST 2026

ICON Acquires Regional CRO for Patient Access in Europe and Africa

ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, announced that it has acquired...

NovaGo Therapeutics Raises CHF 10 Million to Develop Regenerative Anti-Nogo Therapy for Stroke

NovaGo Therapeutics AG, a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke, has closed a Series A financing round...

Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision

Aldeyra Therapeutics, Inc. , a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, announced...

Bristol-Myers Squibb to acquire Celgene in $74bn deal

Bristol-Myers Squibb Company and Celgene Corporation announced that they have entered into a definitive merger agreement under which Bristol-Myers Squibb will acquire Celgene in...

Arsanis and X4 Pharmaceuticals enter into a definitive merger agreement

Arsanis, Inc. and privately-held X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics designed to improve immune...

Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline

Allergan plc , a leading global pharmaceutical company, announced it has agreed to acquire Bonti, Inc., a privately held clinical-stage biotechnology company focused on...

Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins

Ziylo and Novo Nordisk A/S announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...